Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Venetoclax and Ibrutinib in Patients With Relapsed/Refractory CLL or SLL

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03045328
Recruitment Status : Active, not recruiting
First Posted : February 7, 2017
Last Update Posted : July 23, 2019
Sponsor:
Information provided by (Responsible Party):
Steven E. Coutre, Stanford University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : September 2021
Estimated Study Completion Date : September 2022